At Neurolign Technologies, innovation and science are in our DNA.

We are dedicated to creating a quantum shift in the diagnosis
and treatment of neurological disorders.

Through the unique combination of high precision medical devices as well as specialty formulations and drug delivery technologies, we are creating a revolutionary approach to the screening and treatment of neurological disorders, beginning with concussion. Whether you are a patient or a medical professional, our world class diagnostics and novel therapeutics can support the pursuit of optimal brain health and wellness.

Acquisition News

On September 20th, 2019, Neurolign Technologies Inc. ("Neurolign"), announced the acquisition of Neuro Kinetics Inc. (“NKI”) of Pittsburgh, Pennsylvania. Neuro Kinetics Inc. is a leader in its field, providing eye-tracking diagnostic platforms that deliver, leading edge, neuro-functional assessments and monitoring to identify more than 200 diseases and medical conditions (www.neuro-kinetics.com). With over 90 variables and 14 FDA cleared tests, NKI has the most precise and data-rich eye-tracking solution in the Global market to date. NKI’s solutions, including its key assets, I-PAS™ and I-Portal™ are foundational platforms helping clinicians detect multiple medical conditions early, accurately, and cost effectively. I-Portal’s non-invasive Science to See™ is enabling NKI to expand its presence from its historic vestibular market into new arenas and applications in traumatic brain injury, concussion, ophthalmology, and neurology. “With this investment in NKI, we are on a rapid trajectory to provide objective and novel approaches, becoming the preeminent leader in neurological diagnostics and therapeutics impacting all dimensions of brain health”, added CEO Eugene Melnyk. To read more click here.

Brain health by the numbers

45-60 Million People are impacted each year by concussion5

Up to 30% of concussions go undiagnosed and untreated6

Brain injury is the #1 cause of death and disability globally among children, youth and those under age 44



Meet the leadership team that is pushing boundaries to revolutionize the way we diagnose and treat neurological disorders.

Eugene Melnyk

Eugene Melnyk is the Chairman and Chief Executive Officer at Neurolign. Eugene began his career by creating the medical publishing company Trimel Corporation. Eugene went on to become Founder and Chairman of Biovail Corporation, a specialty pharmaceutical company focused on research and development of advanced drug delivery technologies. Under his leadership, Biovail became Canada’s largest publicly traded pharmaceutical company, generating more than $1 billion in annual revenue. Eugene is also the owner, governor and chairman of the Ottawa Senators Hockey Club and Canadian Tire Centre. In 2014, Eugene was formally recognized for his support of the military by Canada’s then Minister of National Defence, the Honorable Rob Nicholson, when he was appointed as the Honorary Colonel of the 414 Electronic Warfare Squadron of the Canadian Armed Forces.

Derek Clark

Derek Clark is the Chief Operating Officer at Neurolign.  Derek was most recently the Chief Commercial Officer for GE Canada, where he was responsible for driving growth across all GE Businesses in Canada.  The majority of Derek’s 20 years at GE were in progressive leadership roles in the Healthcare business unit, in the commercialization of medical devices in diagnostic imaging, patient monitoring, IT and services.  He holds a Bachelor’s degree in Mechanical Engineering and Management from McMaster University and a Master’s in Business Administration from the University of Western Ontario’s Ivey School of Business.

Learn More

Sandeep Grover

Sandeep Grover is the Chief Information Officer at Neurolign. Sandeep was most recently the CIO for Armstrong Fluid Technology, where he was responsible for driving global transformation of legacy platform to Integrated Enterprise software, using AI and IOT. Prior to that, Sandeep has led significant transformations at Commercial, manufacturing and Supply chain at GE & Blackberry. He holds a Bachelor’s degree in Commerce from Delhi University and Advanced Studies in Systems Management from National Institute of Information Technology.

Learn More

Sanam Basirian

Sanam Basirian is the Senior Director of Business Development at Neurolign. With over 15 years of experience in the healthcare industry, Sanam brings a wealth of commercial expertise to the team. She has held progressive leadership roles in business development and sales within global multinationals, including Cerner Corporation, where she led and directed teams to drive profitable market growth. In a previous position as Director of Sales for Logibec, Sanam was instrumental in driving the organization’s national growth strategy and supporting the successful commercial transition of various mergers and acquisitions. Sanam graduated from McGill University where she earned a degree in Biochemistry and is an active member of HIMSS and Digital Health Canada.

Learn More

Natalie Ceccato

Natalie Ceccato is the Senior Director of Business and Market Intelligence at Neurolign. Natalie has held leadership roles building, transforming and championing insight departments across the health care system for over 15 years. Most recently she led the development of research, analytics and insight functions at LifeLabs as the Director of Business Insights and Customer Experience. Her expertise centers on integrating research, market and competitive intelligence, customer and business analytics into actionable insights to drive strategy development and execution. She holds a Master of Science degree from McMaster University and a Doctorate of Public Health Science from the University of Toronto.

Learn More

Contact Us